Lineage Cell Therapeutics, Inc. (LCTX)
0.82
-0.02
(-2.21%)
USD |
NYAM |
Nov 19, 16:00
0.841
+0.02
(+2.56%)
After-Hours: 07:41
Lineage Cell Therapeutics Shareholders Equity (Quarterly) : 67.06M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 67.06M |
| June 30, 2026 | 60.92M |
| March 31, 2026 | 53.88M |
| December 31, 2025 | 44.55M |
| September 30, 2025 | 22.04M |
| June 30, 2025 | 48.38M |
| March 31, 2025 | 79.03M |
| December 31, 2024 | 78.38M |
| September 30, 2024 | 66.19M |
| June 30, 2024 | 68.30M |
| March 31, 2024 | 72.40M |
| December 31, 2023 | 63.42M |
| September 30, 2023 | 68.12M |
| June 30, 2023 | 72.67M |
| March 31, 2023 | 70.45M |
| December 31, 2022 | 73.34M |
| September 30, 2022 | 78.95M |
| June 30, 2022 | 82.85M |
| March 31, 2022 | 86.55M |
| December 31, 2021 | 92.22M |
| September 30, 2021 | 120.71M |
| June 30, 2021 | 124.71M |
| March 31, 2021 | 117.67M |
| December 31, 2020 | 96.20M |
| September 30, 2020 | 91.27M |
| Date | Value |
|---|---|
| June 30, 2020 | 99.44M |
| March 31, 2020 | 106.50M |
| December 31, 2019 | 112.96M |
| September 30, 2019 | 117.16M |
| June 30, 2019 | 133.39M |
| March 31, 2019 | 162.84M |
| December 31, 2018 | 93.84M |
| September 30, 2018 | 171.13M |
| June 30, 2018 | 100.98M |
| March 31, 2018 | 99.97M |
| December 31, 2017 | 162.64M |
| September 30, 2017 | 198.29M |
| June 30, 2017 | 176.12M |
| March 31, 2017 | 187.37M |
| December 31, 2016 | 117.93M |
| September 30, 2016 | 119.39M |
| June 30, 2016 | 85.74M |
| March 31, 2016 | 10.85M |
| December 31, 2015 | 26.89M |
| September 30, 2015 | 13.04M |
| June 30, 2015 | 16.98M |
| March 31, 2015 | 26.25M |
| December 31, 2014 | 36.46M |
| September 30, 2014 | 10.98M |
| June 30, 2014 | 17.91M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Curis, Inc. | 2.551M |
| Armata Pharmaceuticals, Inc. | -174.13M |
| Voyager Therapeutics, Inc. | 135.11M |
| Black Diamond Therapeutics, Inc. | 88.08M |
| Invivyd, Inc. | 150.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 100.11M |
| Total Liabilities (Quarterly) | 34.17M |
| Debt to Equity Ratio | 0.0303 |
| Current Ratio | 5.958 |
| Net Debt Paydown Yield | 0.01% |